Citation: | WU Shengnan, JIANG Huanyu, CHEN Haoran, WANG Xinyao, WU Jiahui, WANG Luqi. Differentially expressed genes of ulcerative colitis and associated microRNAs based on bioinformatics analysis[J]. Journal of Clinical Medicine in Practice, 2024, 28(1): 48-55. DOI: 10.7619/jcmp.20233250 |
To analyze differentially expressed genes and potential microRNA (miRNAs) with diagnostic and therapeutic potential in ulcerative colitis (UC) based on bioinformatics.
The chip raw data in GEO database was screened by weighted gene coexpression network analysis. UC related differentially expressed genes were obtained for enrichment analysis. Potential miRNAs associated with differentially expressed genes were predicted based on key genes, and gene-miRNA regulatory networks were constructed.
A total of 277 differentially expressed genes were screened, of which 200 genes were up-regulated and 77 genes were down-regulated. Gene set enrichment analysis (GSEA) showed that the main enrichment pathways were neuroactive ligand-receptor interaction, leishmania infection, prion disease and electrocardiogram receptor interaction. The results of gene ontology (GO) analysis showed that it was mainly involved in chemokine activity, heparin binding as well as chemokine receptor binding and other items. The Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that the main enrichment pathways were cytokine receptor interaction pathway, phosphatidylinositol-3 kinase/protein kinase B(PI3K-AKT) signaling pathway, chemokine signaling pathway as well as nuclear transcription factor kappa B(NF-κB) signaling pathway and other pathway. A total of 10 hub genes were screened: C-X-C chemokine ligand 8 (CXCL8), Toll-like receptor 2 (TLR2), intercellular adhesion molecule-1 (ICAM-1), selectin L (SELL), C-X-C chemokine receptor type 4 (CXCR4), cytotoxic T lymphocyte associated antigen 4 (CTLA4), cluster of differentiation 69 (CD69), and Biglycan (BGN), C-X-C chemokine ligand 13 (CXCL13), tissue inhibitor of metalloproteinases 1(TIMP1). A total of 12 potentially key miRNAs were identified, they were respectively hsa-mir-335-5p, hsa-mir-146a-5p, hsa-mir-92a-3p, hsa-mir-155-5p, hsa-mir-26b-5p, hsa-mir-4426, hsa-mir-4462b, hsa-mir-4647, hsa-mir-32-5p, hsa-mir-92b-3p, hsa-mir-98-5p and hsa-mir-93-5p, respectively.
In this study, a total of 277 differentially expressed genes are screened for possible involvement in the development of UC, and 10 hub genes and 12 miRNAs are identified as possible biomarkers for UC.
[1] |
李军祥, 陈誩. 溃疡性结肠炎中西医结合诊疗共识意见(2017年)[J]. 中国中西医结合消化杂志, 2018, 26(2): 105-111, 120.
|
[2] |
吴开春, 梁洁, 冉志华, 等. 炎症性肠病诊断与治疗的共识意见(2018年·北京)[J]. 中国实用内科杂志, 2018, 38(9): 796-813.
|
[3] |
张雪莹, 单海燕, 薄淑萍. 隔药灸神阙八阵穴联合角调五音疗法治疗溃疡性结肠炎伴焦虑抑郁状态效果观察[J]. 天津中医药大学学报, 2019, 38(1): 38-41.
|
[4] |
FEUERSTEIN J D, CHEIFETZ A S. Ulcerative colitis: epidemiology, diagnosis, and management[J]. Mayo Clin Proc, 2014, 89(11): 1553-1563. doi: 10.1016/j.mayocp.2014.07.002
|
[5] |
HE X X, LI Y H, YAN P G, et al. Relationship between clinical features and intestinal microbiota in Chinese patients with ulcerative colitis[J]. World J Gastroenterol, 2021, 27(28): 4722-4737. doi: 10.3748/wjg.v27.i28.4722
|
[6] |
LUO R, HUO L, ZHANG J, et al. Meta-analysis on causes of ulcerative colitis[J]. Zhonghua Liu Xing Bing Xue Za Zhi, 2015, 36(12): 1419-1423.
|
[7] |
李娜, 陶弘武, 柳越冬, 等. 基于生物信息学的溃疡性结肠炎免疫细胞的浸润模式分析[J]. 中国免疫学杂志, 2020, 36(24): 2966-2970, 2975.
|
[8] |
CHEN H M, WU X H, XU C J, et al. Dichotomous roles of neutrophils in modulating pathogenic and repair processes of inflammatory bowel diseases[J]. Precis Clin Med, 2021, 4(4): 246-257. doi: 10.1093/pcmedi/pbab025
|
[9] |
RABE H, MALMQUIST M, BARKMAN C, et al. Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease[J]. Clin Exp Immunol, 2019, 197(1): 111-129. doi: 10.1111/cei.13294
|
[10] |
CHOWDHURY D, CHOI Y E, BRAULT M E. Charity begins at home: non-coding RNA functions in DNA repair[J]. Nat Rev Mol Cell Biol, 2013, 14(3): 181-189. doi: 10.1038/nrm3523
|
[11] |
HU B C, WANG X, HU S F, et al. MiR-21-mediated radioresistance occurs via promoting repair of DNA double strand breaks[J]. J Biol Chem, 2017, 292(8): 3531-3540. doi: 10.1074/jbc.M116.772392
|
[12] |
LAM J K, CHOW M Y, ZHANG Y, et al. siRNA versus miRNA as therapeutics for gene silencing[J]. Mol Ther Nucleic Acids, 2015, 4(9): e252.
|
[13] |
胡敏, 王朴, 潘素跃, 等. 基于生物信息学方法探讨特应性皮炎免疫浸润机制及相关中药预测[J]. 中国免疫学杂志, 2023: 1-24. doi: 10.3969/j.issn.1000-484X.2023.01.001
|
[14] |
ZHOU G Y, SOUFAN O, EWALD J, et al. NetworkAnalyst 3. 0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis[J]. Nucleic Acids Res, 2019, 47(W1): W234-W241. doi: 10.1093/nar/gkz240
|
[15] |
苏晓路, 董弛, 张静, 等. 溃疡性结肠炎临床病理特点及鉴别诊断[J]. 生物医学转化, 2022, 3(2): 66-74.
|
[16] |
VENY M, FERNÁNDEZ-CLOTET A, PANÉS J. Controlling leukocyte trafficking in IBD[J]. Pharmacol Res, 2020, 159: 105050. doi: 10.1016/j.phrs.2020.105050
|
[17] |
LIU J Q, LIU J, TONG X L, et al. Network pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of Huai Hua san against ulcerative colitis[J]. Drug Des Devel Ther, 2021, 15: 3255-3276. doi: 10.2147/DDDT.S319786
|
[18] |
ZHU Y F, YANG S H, ZHAO N, et al. CXCL8 chemokine in ulcerative colitis[J]. Biomedecine Pharmacother, 2021, 138: 111427. doi: 10.1016/j.biopha.2021.111427
|
[19] |
HA H, DEBNATH B, NEAMATI N. Role of the CXCL8-CXCR1/2 axis in cancer and inflammatory diseases[J]. Theranostics, 2017, 7(6): 1543-1588. doi: 10.7150/thno.15625
|
[20] |
李冬璇, 韩秋菊, 张建. TLR2免疫调节作用的研究进展[J]. 现代免疫学, 2022, 42(1): 82-85.
|
[21] |
BUI T M, WIESOLEK H L, SUMAGIN R. ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis[J]. J Leukoc Biol, 2020, 108(3): 787-799. doi: 10.1002/JLB.2MR0220-549R
|
[22] |
LIU Z H, YAGO T, ZHANG N, et al. L-selectin mechanochemistry restricts neutrophil priming in vivo[J]. Nat Commun, 2017, 8: 15196. doi: 10.1038/ncomms15196
|
[23] |
SILVA-CARDOSO S C, TAO W Y, ANGIOLILLI C, et al. CXCL4 links inflammation and fibrosis by reprogramming monocyte-derived dendritic cells in vitro[J]. Front Immunol, 2020, 11: 2149. doi: 10.3389/fimmu.2020.02149
|
[24] |
HU W T, FANG T Y, ZHOU M X, et al. Identification of hub genes and immune infiltration in ulcerative colitis using bioinformatics[J]. Sci Rep, 2023, 13(1): 6039. doi: 10.1038/s41598-023-33292-y
|
[25] |
HU W T, FANG T Y, CHEN X Q. Identification of differentially expressed genes and miRNAs for ulcerative colitis using bioinformatics analysis[J]. Front Genet, 2022, 13: 914384. doi: 10.3389/fgene.2022.914384
|
[26] |
WANG Y, ZHUANG H, JIANG X H, et al. Unveiling the key genes, environmental toxins, and drug exposures in modulating the severity of ulcerative colitis: a comprehensive analysis[J]. Front Immunol, 2023, 14: 1162458. doi: 10.3389/fimmu.2023.1162458
|
[27] |
XU W Q, ZHANG Z W, YAO L H, et al. Exploration of shared gene signatures and molecular mechanisms between periodontitis and nonalcoholic fatty liver disease[J]. Front Genet, 2022, 13: 939751. doi: 10.3389/fgene.2022.939751
|
[28] |
HOU Y, QIAO S J, LI M, et al. The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit[J]. Front Genet, 2022, 13: 1090640.
|
[29] |
ZHOU J, LIU J L, GAO Y Y, et al. miRNA-based potential biomarkers and new molecular insights in ulcerative colitis[J]. Front Pharmacol, 2021, 12: 707776. doi: 10.3389/fphar.2021.707776
|
[30] |
LUO J, WANG Y J, LAN D F, et al. Differential expression of serum microRNAs in glucocorticoid-resistant patients with ulcerative colitis[J]. Int J Clin Exp Pathol, 2018, 11(2): 936-946.
|
[31] |
WANG Y, WANG N, CUI L L, et al. Long non-coding RNA MEG3 alleviated ulcerative colitis through upregulating miR-98-5p-sponged IL-10[J]. Inflammation, 2021, 44(3): 1049-1059. doi: 10.1007/s10753-020-01400-z
|
[32] |
CHEN Z P, GU Q L, CHEN R C. MiR-146a-5p regulates autophagy and NLRP3 inflammasome activation in epithelial barrier damage in the in vitro cell model of ulcerative colitis through the RNF8/Notch1/mTORC1 pathway[J]. Immunobiology, 2023, 228(4): 152386. doi: 10.1016/j.imbio.2023.152386
|
[33] |
PATHAK S, GRILLO A R, SCARPA M, et al. MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis[J]. Exp Mol Med, 2015, 47(5): e164. doi: 10.1038/emm.2015.21
|
[34] |
WU C P, BI Y J, LIU D M, et al. Hsa-miR-375 promotes the progression of inflammatory bowel disease by upregulating TLR4[J]. Eur Rev Med Pharmacol Sci, 2019, 23(17): 7543-7549.
|
[35] |
YUAN Y F, LI N, FU M Y, et al. Identification of critical modules and biomarkers of ulcerative colitis by using WGCNA[J]. J Inflamm Res, 2023, 16: 1611-1628. doi: 10.2147/JIR.S402715
|